MarketInOut Stock Screener Log In | Sign Up
 

EDAP TMS S.A. ADR

NASDAQ • Healthcare • Medical Distribution • Quote as of 10/23/2026
EDAP TMS S.A. ADR stock price and volume chart

Company Profile

IndustryMedical Distribution
SectorHealthcare
ExchangeNASDAQ
Market Capitalization195.95 mln
Float37.28 mln
Earnings Date11/05/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-5.04
Highly reliable

1-Year Forecast

8.80
Transformational upside

Relative Strength

59 / 100
Slightly ahead

Pre-Tax Margin

-56%
Severely loss-making

ROE

-225
Deeply negative

Business Description

Founded in 1979 and based in France, EDAP TMS operates as a medical technology company focused on non-invasive ultrasound-based treatment devices, with its flagship product being the Focal One robotic system used to treat prostate cancer. The company also produces equipment for breaking down urinary tract stones and distributes complementary medical devices from other manufacturers, serving hospitals and clinics across Asia, Europe, the United States, and beyond. Products reach customers through both a direct sales force and third-party distributors, with additional revenue coming from device leasing, disposable supplies, and maintenance services.

Key Fundamentals

EPS-1.34
ROE-225
RPS2.12
ROIC-67.97
ROA-51.44
Interest Cover-4.92
EBITDA, mln-25.50
EV / EBITDA-7.37
EV / EBIT-6.86
Revenue, mln69.14
EV / Revenue2.72

Quote Details

Last 4.17
Change 0.02 (0.48%)
Open 4.48
Volume 27,393
Turnover 114,229
Average Volume 59,190

Financial Ratios

Pre-Tax Profit Margin-56
Current Ratio1.60
Price / Sales2.41

Financial Strength

Altman Z-Score-1.47
Piotroski F-Score 4 / 9
Beneish M-Score-5.04
1-Year Target Price8.80
Short Ratio3.17
Short % of Float0.68

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 1.96% 78 / 100   
1 Month -9.15% 31 / 100   
2 Months -25.67% 19 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog